| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8646170 | Gene Reports | 2018 | 34 Pages |
Abstract
Hsa-miR-101-3p can highly discriminate between malignant and non-malignant samples in BTCC, and seems to associate with tumor progression and aggressiveness. It might be a promising diagnostic and perhaps prognostic marker for BTCC.
Keywords
FGFR3rRNAPompB cell lymphoma-2EZH2NGALMMP-9Bcl-2Mcl-1RT-qPCRmRNAc-Metmessenger RNARibosomal RNAmicro RNAenhancer of zeste homologue 2real time quantitative polymerase chain reactionBladder cancerneutrophil gelatinase-associated lipocalinMatrix metalloproteinase 9bladder transitional cell carcinomaFibroblast Growth Factor Receptor 3
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Genetics
Authors
Yasmine A. Issa, Howaida A. Nounou, Mohamed M. Hashad,